Evolocumab, a cholesterol-lowering drug typically reserved for people with known cardiovascular disease, reduces risk of first-time heart attack and stroke in high-risk patients with diabetes. The ...

Twice a year, a nurse slides a small needle under the skin of your upper arm. Thirty seconds later, you are done. No daily ...

A study showed cholesterol-lowering statins do not significantly affect ALS progression or survival. Statin prescriptions for ALS patients should be based on metabolic needs, not ALS diagnosis. More ...

The results of a phase three clinical trial for a cholesterol-lowering drug have shown that this drug, called enlicitide, can reduce the levels of low-density lipoprotein (LDL) cholesterol by 60% ...

WASHINGTON (AP) — A new kind of pill sharply reduced artery-clogging cholesterol in people who remain at high risk of heart attacks despite taking statins, researchers reported Wednesday. It’s still ...

Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology.

Millions of Americans struggle with high cholesterol, a major risk factor for heart disease. While medication helps many, ...

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo March 30 (Reuters) - Merck's oral drug reduced bad ...

They’ll support your overall heart health, too.

High LDL cholesterol can sneak up on you. It happens slowly over time and causes no symptoms whatsoever. According to a study published in JAMA Cardiology, 42.7% of U.S. adults with high LDL ...